BOZEN, Italy, August 10 /PRNewswire/ --
- Strategic Partnership Announced With Health Robotics
Health Robotics today announced that it has signed an exclusive five-year strategic partnership with McKesson for Health Robotics' CytoCare Robot. The agreement enables McKesson to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. admixtures.
"We are very pleased to have been chosen by Health Robotics as their exclusive CytoCare partner in our core markets of the United States and Canada", stated David Souerwine, President, McKesson Automation. "CytoCare, a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) and MedCarousel(R) technologies, and our entire suite of Automation solutions."
McKesson believes that CytoCare has the potential to become the gold
standard for Oncology I.V. admixtures in North America, equally protecting
clinicians and patients. The successful installations of the CytoCare Robot
in the United States, including the
"McKesson is the ideal partner for Health Robotics in North America due
to its commitment to medication safety, company stability, market footprint,
world-class service infrastructure, and complementary oral medication
automation technologies. I was extremely impressed to see their manufacturing
and customer services operations in Pittsburgh; they are exactly what
CytoCare customers need in North America: a knowledgeable, committed,
resourceful, and customer-focused organization. This is precisely what Health
Robotics requires at this moment in time to take CytoCare to the next level
of market acceptance and customer-service focus in North America. I'm sure
this is just the beginning of a
|SOURCE Health Robotics|
Copyright©2009 PR Newswire.
All rights reserved